{"hands_on_practices": [{"introduction": "A cornerstone of successful formulation development is ensuring the chemical stability of the active pharmaceutical ingredient. For many drugs, especially those administered parenterally, stability is highly dependent on pH. This practice focuses on the fundamental concept of buffer capacity, which quantifies a solution's ability to resist pH changes. By deriving the buffer capacity expression from first principles, you will gain a deep, quantitative understanding of how to design and optimize buffer systems to maintain drug integrity and ensure patient safety [@problem_id:5015833].", "problem": "A parenteral formulation intended for intravenous administration uses a sodium phosphate buffer to maintain chemical stability of a labile small-molecule drug during storage and infusion. At temperature $25\\,^{\\circ}\\mathrm{C}$, the formulation contains a total analytical phosphate concentration $C_{\\mathrm{P}} = 0.020~\\mathrm{mol}\\,\\mathrm{L}^{-1}$ and is adjusted to a $\\mathrm{pH}$ (potential of hydrogen) of $7.40$. Near neutral $\\mathrm{pH}$, the relevant phosphate acid-base pair is $\\mathrm{H_{2}PO_{4}^{-}}/\\mathrm{HPO_{4}^{2-}}$, governed by the second dissociation of phosphoric acid with acid dissociation constant $K_{a,2}$. Assume ideal solution behavior (activity coefficients equal to $1$), negligible volume change upon titration, and that, at this $\\mathrm{pH}$, contributions from $\\mathrm{H_{3}PO_{4}}$ and $\\mathrm{PO_{4}^{3-}}$ can be neglected. The ionic product of water at $25\\,^{\\circ}\\mathrm{C}$ is $K_{w}$.\n\nStarting strictly from the law of mass action, conservation of mass for total phosphate, and conservation of protons under addition of a strong acid, derive the expression for the buffer capacity $\\beta$ defined as the positive quantity equal to the absolute value of the slope of the number of moles of added strong acid per liter with respect to $\\mathrm{pH}$ at constant temperature and volume. Then compute $\\beta$ at $\\mathrm{pH}=7.40$ using $K_{a,2} = 6.31 \\times 10^{-8}$ and $K_{w} = 1.00 \\times 10^{-14}$. \n\nExpress your final answer in $\\mathrm{mol}\\,\\mathrm{L}^{-1}$ per unit $\\mathrm{pH}$ and round your answer to four significant figures.", "solution": "The problem requires the derivation of the buffer capacity, $\\beta$, for a sodium phosphate buffer system, followed by its calculation at a specific $\\mathrm{pH}$. The derivation must start from fundamental principles.\n\n### Step 1: Derivation of the Buffer Capacity Expression\n\nThe buffer capacity $\\beta$ is defined as the positive quantity equal to the absolute value of the slope of the number of moles of added strong acid per liter, $C_A$, with respect to $\\mathrm{pH}$. Mathematically, this is $\\beta = |\\frac{dC_A}{d(\\mathrm{pH})}|$. Since adding a strong acid decreases the $\\mathrm{pH}$, the derivative $\\frac{dC_A}{d(\\mathrm{pH})}$ is negative. Therefore, the definition is equivalent to the standard definition of buffer index, $\\beta = -\\frac{dC_A}{d(\\mathrm{pH})}$.\n\nWe begin by establishing the governing equations for the system at equilibrium.\n1.  **Law of Mass Action for Water:** The autoionization of water is described by the ionic product of water, $K_w$.\n    $$K_w = [\\mathrm{H}^{+}] [\\mathrm{OH}^{-}]$$\n\n2.  **Law of Mass Action for Phosphate Buffer:** Near neutral $\\mathrm{pH}$, the relevant equilibrium is the second dissociation of phosphoric acid ($\\mathrm{H_3PO_4}$), involving the conjugate acid-base pair $\\mathrm{H_2PO_4^{-}}/\\mathrm{HPO_4^{2-}}$.\n    $$\\mathrm{H_2PO_4^{-}} \\rightleftharpoons \\mathrm{H}^{+} + \\mathrm{HPO_4^{2-}}$$\n    The corresponding acid dissociation constant is $K_{a,2}$.\n    $$K_{a,2} = \\frac{[\\mathrm{H}^{+}] [\\mathrm{HPO_4^{2-}}]}{[\\mathrm{H_2PO_4^{-}}]}$$\n\n3.  **Conservation of Mass for Phosphate:** The total analytical concentration of phosphate, $C_P$, is the sum of the concentrations of the species $\\mathrm{H_2PO_4^{-}}$ and $\\mathrm{HPO_4^{2-}}$, as the contributions from $\\mathrm{H_3PO_4}$ and $\\mathrm{PO_4^{3-}}$ are assumed negligible.\n    $$C_P = [\\mathrm{H_2PO_4^{-}}] + [\\mathrm{HPO_4^{2-}}]$$\n\n4.  **Conservation of Protons (Charge Balance):** To derive an expression for $C_A$, we formulate the charge balance equation. Let us model the system as being prepared by adding a concentration $C_A$ of a strong monoprotic acid (e.g., HCl) to a solution containing a total phosphate concentration $C_P$ prepared from its conjugate base form, $\\mathrm{Na_2HPO_4}$. The species in solution are $\\mathrm{Na}^{+}$, $\\mathrm{H}^{+}$, $\\mathrm{OH}^{-}$, $\\mathrm{H_2PO_4^{-}}$, $\\mathrm{HPO_4^{2-}}$, and the anion from the strong acid, $\\mathrm{Cl}^{-}$.\n    The charge balance equation is:\n    $$[\\mathrm{Na}^{+}] + [\\mathrm{H}^{+}] = [\\mathrm{OH}^{-}] + [\\mathrm{H_2PO_4^{-}}] + 2[\\mathrm{HPO_4^{2-}}] + [\\mathrm{Cl}^{-}]$$\n    From our preparation model, the sodium ion concentration is twice the total phosphate concentration, $[\\mathrm{Na}^{+}] = 2C_P$, and the chloride ion concentration equals the concentration of added strong acid, $[\\mathrm{Cl}^{-}] = C_A$. Substituting these into the charge balance equation gives:\n    $$2C_P + [\\mathrm{H}^{+}] = [\\mathrm{OH}^{-}] + [\\mathrm{H_2PO_4^{-}}] + 2[\\mathrm{HPO_4^{2-}}] + C_A$$\n    We substitute the mass balance equation, $C_P = [\\mathrm{H_2PO_4^{-}}] + [\\mathrm{HPO_4^{2-}}]$, into this expression:\n    $$2([\\mathrm{H_2PO_4^{-}}] + [\\mathrm{HPO_4^{2-}}]) + [\\mathrm{H}^{+}] = [\\mathrm{OH}^{-}] + [\\mathrm{H_2PO_4^{-}}] + 2[\\mathrm{HPO_4^{2-}}] + C_A$$\n    Simplifying the equation by canceling terms:\n    $$[\\mathrm{H_2PO_4^{-}}] + [\\mathrm{H}^{+}] = [\\mathrm{OH}^{-}] + C_A$$\n    Rearranging to solve for $C_A$:\n    $$C_A = [\\mathrm{H_2PO_4^{-}}] + [\\mathrm{H}^{+}] - [\\mathrm{OH}^{-}]$$\n\nNow, we differentiate $C_A$ with respect to $\\mathrm{pH}$ to find $\\beta$. To do this, we must first express all terms on the right-hand side as functions of $[\\mathrm{H}^{+}]$.\nFrom the mass balance and $K_{a,2}$ expressions:\n$[\\mathrm{H_2PO_4^{-}}] = C_P - [\\mathrm{HPO_4^{2-}}]$ and $[\\mathrm{HPO_4^{2-}}] = K_{a,2} \\frac{[\\mathrm{H_2PO_4^{-}}]}{[\\mathrm{H}^{+}]}$.\n$C_P = [\\mathrm{H_2PO_4^{-}}] + K_{a,2} \\frac{[\\mathrm{H_2PO_4^{-}}]}{[\\mathrm{H}^{+}]} = [\\mathrm{H_2PO_4^{-}}] \\left(1 + \\frac{K_{a,2}}{[\\mathrm{H}^{+}]}\\right) = [\\mathrm{H_2PO_4^{-}}] \\frac{[\\mathrm{H}^{+}] + K_{a,2}}{[\\mathrm{H}^{+}]}$.\nThus, $[\\mathrm{H_2PO_4^{-}}] = C_P \\frac{[\\mathrm{H}^{+}]}{[\\mathrm{H}^{+}] + K_{a,2}}$.\nAlso, $[\\mathrm{OH}^{-}] = \\frac{K_w}{[\\mathrm{H}^{+}]}$.\nSubstituting these into the expression for $C_A$:\n$$C_A = C_P \\frac{[\\mathrm{H}^{+}]}{[\\mathrm{H}^{+}] + K_{a,2}} + [\\mathrm{H}^{+}] - \\frac{K_w}{[\\mathrm{H}^{+}]}$$\nWe now differentiate $C_A$ with respect to $\\mathrm{pH}$. We use the chain rule, noting that $\\frac{d}{d(\\mathrm{pH})} = \\frac{d[\\mathrm{H}^{+}]}{d(\\mathrm{pH})} \\frac{d}{d[\\mathrm{H}^{+}]}$ and that $\\frac{d[\\mathrm{H}^{+}]}{d(\\mathrm{pH})} = \\frac{d}{d(\\mathrm{pH})}(10^{-\\mathrm{pH}}) = -(\\ln 10) \\times 10^{-\\mathrm{pH}} = -(\\ln 10)[\\mathrm{H}^{+}]$.\n\nLet's find the derivatives of each term in the $C_A$ expression with respect to $\\mathrm{pH}$:\n- Term 1: $\\frac{d[\\mathrm{H}^{+}]}{d(\\mathrm{pH})} = -(\\ln 10)[\\mathrm{H}^{+}]$.\n- Term 2: $\\frac{d[\\mathrm{OH}^{-}]}{d(\\mathrm{pH})} = \\frac{d}{d(\\mathrm{pH})} \\left( \\frac{K_w}{[\\mathrm{H}^{+}]} \\right) = -\\frac{K_w}{[\\mathrm{H}^{+}]^2} \\frac{d[\\mathrm{H}^{+}]}{d(\\mathrm{pH})} = -\\frac{K_w}{[\\mathrm{H}^{+}]^2} (-(\\ln 10)[\\mathrm{H}^{+}]) = (\\ln 10)\\frac{K_w}{[\\mathrm{H}^{+}]} = (\\ln 10)[\\mathrm{OH}^{-}]$.\n- Term 3: $\\frac{d[\\mathrm{H_2PO_4^{-}}]}{d(\\mathrm{pH})} = \\frac{d[\\mathrm{H_2PO_4^{-}}]}{d[\\mathrm{H}^{+}]} \\frac{d[\\mathrm{H}^{+}]}{d(\\mathrm{pH})}$.\nFirst, derivative with respect to $[\\mathrm{H}^{+}]$ using the quotient rule:\n$\\frac{d}{d[\\mathrm{H}^{+}]} \\left( C_P \\frac{[\\mathrm{H}^{+}]}{[\\mathrm{H}^{+}] + K_{a,2}} \\right) = C_P \\frac{([\\mathrm{H}^{+}] + K_{a,2})(1) - [\\mathrm{H}^{+}](1)}{([\\mathrm{H}^{+}] + K_{a,2})^2} = C_P \\frac{K_{a,2}}{([\\mathrm{H}^{+}] + K_{a,2})^2}$.\nNow multiply by $\\frac{d[\\mathrm{H}^{+}]}{d(\\mathrm{pH})}$:\n$\\frac{d[\\mathrm{H_2PO_4^{-}}]}{d(\\mathrm{pH})} = \\left( C_P \\frac{K_{a,2}}{([\\mathrm{H}^{+}] + K_{a,2})^2} \\right) \\times (-(\\ln 10)[\\mathrm{H}^{+}]) = -(\\ln 10) C_P \\frac{K_{a,2}[\\mathrm{H}^{+}]}{([\\mathrm{H}^{+}] + K_{a,2})^2}$.\n\nNow we assemble the derivative $\\frac{dC_A}{d(\\mathrm{pH})}$:\n$$\\frac{dC_A}{d(\\mathrm{pH})} = \\frac{d[\\mathrm{H_2PO_4^{-}}]}{d(\\mathrm{pH})} + \\frac{d[\\mathrm{H}^{+}]}{d(\\mathrm{pH})} - \\frac{d[\\mathrm{OH}^{-}]}{d(\\mathrm{pH})}$$\n$$\\frac{dC_A}{d(\\mathrm{pH})} = \\left(-(\\ln 10) C_P \\frac{K_{a,2}[\\mathrm{H}^{+}]}{([\\mathrm{H}^{+}] + K_{a,2})^2}\\right) + \\left(-(\\ln 10)[\\mathrm{H}^{+}]\\right) - \\left((\\ln 10)[\\mathrm{OH}^{-}]\\right)$$\n$$\\frac{dC_A}{d(\\mathrm{pH})} = -(\\ln 10) \\left([\\mathrm{H}^{+}] + [\\mathrm{OH}^{-}] + C_P \\frac{K_{a,2}[\\mathrm{H}^{+}]}{([\\mathrm{H}^{+}] + K_{a,2})^2}\\right)$$\nFinally, we apply the definition $\\beta = -\\frac{dC_A}{d(\\mathrm{pH})}$:\n$$\\beta = (\\ln 10) \\left([\\mathrm{H}^{+}] + [\\mathrm{OH}^{-}] + C_P \\frac{K_{a,2}[\\mathrm{H}^{+}]}{([\\mathrm{H}^{+}] + K_{a,2})^2}\\right)$$\nThis is the derived expression for the buffer capacity.\n\n### Step 2: Calculation of Buffer Capacity $\\beta$\n\nWe are given the following values:\n- Total phosphate concentration, $C_P = 0.020~\\mathrm{mol}\\,\\mathrm{L}^{-1}$\n- $\\mathrm{pH} = 7.40$\n- Acid dissociation constant, $K_{a,2} = 6.31 \\times 10^{-8}$\n- Ionic product of water, $K_w = 1.00 \\times 10^{-14}$\n\nFirst, we calculate the concentrations of $\\mathrm{H}^{+}$ and $\\mathrm{OH}^{-}$ at $\\mathrm{pH} = 7.40$:\n$$[\\mathrm{H}^{+}] = 10^{-\\mathrm{pH}} = 10^{-7.40}~\\mathrm{mol}\\,\\mathrm{L}^{-1} \\approx 3.98107 \\times 10^{-8}~\\mathrm{mol}\\,\\mathrm{L}^{-1}$$\n$$[\\mathrm{OH}^{-}] = \\frac{K_w}{[\\mathrm{H}^{+}]} = \\frac{1.00 \\times 10^{-14}}{10^{-7.40}} = 10^{-6.60}~\\mathrm{mol}\\,\\mathrm{L}^{-1} \\approx 2.51189 \\times 10^{-7}~\\mathrm{mol}\\,\\mathrm{L}^{-1}$$\n\nNow, we substitute these values into the derived expression for $\\beta$. The factor $\\ln(10) \\approx 2.302585$.\nThe buffer capacity is composed of two parts: the contribution from water, $\\beta_w$, and the contribution from the phosphate buffer, $\\beta_P$.\n$$\\beta_w = (\\ln 10) ([\\mathrm{H}^{+}] + [\\mathrm{OH}^{-}]) = 2.302585 \\times (3.98107 \\times 10^{-8} + 2.51189 \\times 10^{-7}) = 2.302585 \\times (2.9100 \\times 10^{-7}) \\approx 6.7005 \\times 10^{-7}~\\mathrm{mol}\\,\\mathrm{L}^{-1}$$\n$$\\beta_P = (\\ln 10) \\left(C_P \\frac{K_{a,2}[\\mathrm{H}^{+}]}{([\\mathrm{H}^{+}] + K_{a,2})^2}\\right)$$\nWe compute the fraction first:\n$$[\\mathrm{H}^{+}] + K_{a,2} = 3.98107 \\times 10^{-8} + 6.31 \\times 10^{-8} = 1.029107 \\times 10^{-7}$$\n$$K_{a,2}[\\mathrm{H}^{+}] = (6.31 \\times 10^{-8}) \\times (3.98107 \\times 10^{-8}) = 2.51206 \\times 10^{-15}$$\n$$\\frac{K_{a,2}[\\mathrm{H}^{+}]}{([\\mathrm{H}^{+}] + K_{a,2})^2} = \\frac{2.51206 \\times 10^{-15}}{(1.029107 \\times 10^{-7})^2} = \\frac{2.51206 \\times 10^{-15}}{1.05906 \\times 10^{-14}} \\approx 0.237199$$\nNow, we calculate $\\beta_P$:\n$$\\beta_P = 2.302585 \\times (0.020~\\mathrm{mol}\\,\\mathrm{L}^{-1}) \\times 0.237199 \\approx 0.0109158~\\mathrm{mol}\\,\\mathrm{L}^{-1}$$\nThe total buffer capacity is the sum of the two contributions:\n$$\\beta = \\beta_w + \\beta_P = 6.7005 \\times 10^{-7}~\\mathrm{mol}\\,\\mathrm{L}^{-1} + 0.0109158~\\mathrm{mol}\\,\\mathrm{L}^{-1} = 0.01091647~\\mathrm{mol}\\,\\mathrm{L}^{-1}$$\nRounding the result to four significant figures as requested gives $0.01092$.", "answer": "$$\\boxed{0.01092}$$", "id": "5015833"}, {"introduction": "Connecting a formulation's physical properties to its in vivo performance is a central challenge in translational medicine. For oral drugs, dissolution in the gastrointestinal tract is a critical rate-limiting step for absorption. This exercise moves beyond simple dissolution tests to model drug release in biorelevant media that mimic the distinct conditions of the stomach and small intestine. By applying principles of mass transport and accounting for complex factors like micellar solubilization, you will learn to build predictive models that are essential for designing effective oral drug delivery systems [@problem_id:5015795].", "problem": "A neutral, poorly water-soluble small-molecule drug is formulated as a monodisperse dispersion of spherical crystals for an immediate-release oral dosage form. To evaluate in vitro performance under gastrointestinally relevant conditions, a two-stage dissolution experiment is planned: Stage 1 in Fasted State Simulated Gastric Fluid (FaSSGF) for $30$ minutes, immediately followed by Stage 2 in Fasted State Simulated Intestinal Fluid (FaSSIF) for an additional $30$ minutes. Assume isothermal conditions at $310$ K and hydrodynamic control by an unstirred boundary layer.\n\nStarting from Fick’s first law of diffusion and the Nernst diffusion-layer concept, and using the Stokes–Einstein relation to account for medium viscosity, derive the governing relation for the evolution of the particle radius in each medium under sink conditions. Then, compute the fraction of undissolved drug remaining at the end of $60$ minutes.\n\nUse the following scientifically plausible and self-consistent parameters:\n- Initial particle radius $r_0 = 50\\,\\mu\\mathrm{m}$ and crystalline density $\\rho = 1200\\,\\mathrm{kg}\\,\\mathrm{m}^{-3}$.\n- Diffusion coefficient of the molecularly dissolved drug in a reference aqueous medium (dynamic viscosity $\\eta_{\\mathrm{ref}} = 0.70\\,\\mathrm{mPa}\\cdot\\mathrm{s}$) is $D_{\\mathrm{ref}} = 6.0 \\times 10^{-10}\\,\\mathrm{m}^2\\,\\mathrm{s}^{-1}$. At constant temperature, diffusion in another medium of viscosity $\\eta$ scales as $D = D_{\\mathrm{ref}} \\, (\\eta_{\\mathrm{ref}}/\\eta)$.\n- Unstirred boundary-layer thicknesses: $h_{\\mathrm{gastric}} = 50\\,\\mu\\mathrm{m}$ in FaSSGF and $h_{\\mathrm{intestine}} = 100\\,\\mu\\mathrm{m}$ in FaSSIF.\n- In FaSSGF, no micelles are present; the intrinsic solubility is $S_{\\mathrm{w}} = 0.020\\,\\mathrm{mg}\\,\\mathrm{mL}^{-1}$.\n- In FaSSIF, bile salt–lecithin mixed micelles are present at total bile salt concentration $[\\mathrm{BS}]_{\\mathrm{tot}} = 15\\,\\mathrm{mM}$ with a critical micelle concentration $\\mathrm{CMC} = 2\\,\\mathrm{mM}$. The apparent interfacial saturation concentration at the crystal surface increases according to a linear solubilization capacity model $C_{s,\\mathrm{app}} = S_{\\mathrm{w}} \\left(1 + K_s \\,([\\mathrm{BS}]_{\\mathrm{tot}} - \\mathrm{CMC})\\right)$, with $K_s = 500\\,\\mathrm{L}\\,\\mathrm{mol}^{-1}$.\n- Dynamic viscosities: $\\eta_{\\mathrm{gastric}} = 0.75\\,\\mathrm{mPa}\\cdot\\mathrm{s}$ for FaSSGF and $\\eta_{\\mathrm{intestine}} = 1.20\\,\\mathrm{mPa}\\cdot\\mathrm{s}$ for FaSSIF.\n- Assume sink conditions throughout both stages, so that the bulk concentration remains negligible compared to the interfacial saturation concentration.\n\nTasks:\n1. Using only fundamental principles (Fick’s first law, Nernst diffusion-layer concept, mass conservation for a shrinking sphere, and the Stokes–Einstein scaling of $D$ with viscosity), derive the expression for the time evolution of the particle radius $r(t)$ in a given medium characterized by $\\eta$, $h$, and $C_s$ under the sink-condition approximation.\n2. Apply the result piecewise over the two stages (FaSSGF for $t_1 = 30$ minutes, then FaSSIF for $t_2 = 30$ minutes) to compute the final radius after $60$ minutes.\n3. Compute the mass fraction of undissolved drug after $60$ minutes, using that the mass of a spherical particle is proportional to $r^3$.\n\nExpress the final undissolved fraction as a decimal fraction and round your answer to four significant figures.", "solution": "The problem is first subjected to validation.\n\n### Step 1: Extract Givens\n-   Initial particle radius: $r_0 = 50\\,\\mu\\mathrm{m}$\n-   Crystalline density: $\\rho = 1200\\,\\mathrm{kg}\\,\\mathrm{m}^{-3}$\n-   Reference diffusion coefficient: $D_{\\mathrm{ref}} = 6.0 \\times 10^{-10}\\,\\mathrm{m}^2\\,\\mathrm{s}^{-1}$\n-   Reference dynamic viscosity: $\\eta_{\\mathrm{ref}} = 0.70\\,\\mathrm{mPa}\\cdot\\mathrm{s}$\n-   Scaling of diffusion coefficient with viscosity $\\eta$: $D = D_{\\mathrm{ref}} \\, (\\eta_{\\mathrm{ref}}/\\eta)$\n-   Boundary-layer thickness in FaSSGF: $h_{\\mathrm{gastric}} = 50\\,\\mu\\mathrm{m}$\n-   Boundary-layer thickness in FaSSIF: $h_{\\mathrm{intestine}} = 100\\,\\mu\\mathrm{m}$\n-   Intrinsic solubility in FaSSGF: $S_{\\mathrm{w}} = 0.020\\,\\mathrm{mg}\\,\\mathrm{mL}^{-1}$\n-   Total bile salt concentration in FaSSIF: $[\\mathrm{BS}]_{\\mathrm{tot}} = 15\\,\\mathrm{mM}$\n-   Critical micelle concentration in FaSSIF: $\\mathrm{CMC} = 2\\,\\mathrm{mM}$\n-   Solubilization capacity constant in FaSSIF: $K_s = 500\\,\\mathrm{L}\\,\\mathrm{mol}^{-1}$\n-   Apparent saturation concentration model in FaSSIF: $C_{s,\\mathrm{app}} = S_{\\mathrm{w}} \\left(1 + K_s \\,([\\mathrm{BS}]_{\\mathrm{tot}} - \\mathrm{CMC})\\right)$\n-   Dynamic viscosity of FaSSGF: $\\eta_{\\mathrm{gastric}} = 0.75\\,\\mathrm{mPa}\\cdot\\mathrm{s}$\n-   Dynamic viscosity of FaSSIF: $\\eta_{\\mathrm{intestine}} = 1.20\\,\\mathrm{mPa}\\cdot\\mathrm{s}$\n-   Duration of Stage 1 (FaSSGF): $t_1 = 30$ minutes\n-   Duration of Stage 2 (FaSSIF): $t_2 = 30$ minutes\n-   Temperature: Isothermal at $310\\,\\mathrm{K}$\n-   Assumption: Sink conditions ($C_{bulk} \\approx 0$)\n\n### Step 2: Validate Using Extracted Givens\nThe problem is assessed for validity.\n-   **Scientifically Grounded**: The problem is based on established principles of mass transport (Fick's law), dissolution theory (Nernst-Brunner model), and biopharmaceutics (two-stage dissolution, micellar solubilization). The use of the Stokes-Einstein relation to account for viscosity effects on diffusion is a standard approach in physical chemistry. All concepts are scientifically sound.\n-   **Well-Posed**: The problem provides a complete set of parameters, initial conditions, and a clear physical model to uniquely determine the final state of the system. The tasks are specified unambiguously.\n-   **Objective**: The problem is stated in precise, quantitative, and unbiased technical language.\n-   **Complete and Consistent**: All necessary data to solve the problem are provided. A check of the units shows them to be consistent. For example, the term $K_s ([\\mathrm{BS}]_{\\mathrm{tot}} - \\mathrm{CMC})$ is dimensionless: $(\\mathrm{L}/\\mathrm{mol}) \\times (\\mathrm{mol}/\\mathrm{L})$, which is consistent with the model for $C_{s,\\mathrm{app}}$. The parameters are physically realistic for a poorly soluble drug in simulated gastrointestinal fluids.\n\n### Step 3: Verdict and Action\nThe problem is valid as it is scientifically sound, well-posed, and all provided data are complete and consistent. We proceed with the solution.\n\n#### Task 1: Derivation of the Governing Relation for Particle Radius\nThe dissolution process is governed by the diffusion of the drug from the particle surface across an unstirred boundary layer.\n\n1.  According to Fick's first law, the mass flux $J$ (mass per unit area per time) is proportional to the concentration gradient. Using the Nernst diffusion-layer concept, this gradient is linearized across the boundary layer of thickness $h$:\n    $$ J = D \\frac{C_s - C_b}{h} $$\n    where $D$ is the diffusion coefficient, $C_s$ is the saturation concentration at the particle surface, and $C_b$ is the concentration in the bulk fluid. Under sink conditions, $C_b \\ll C_s$, so we can approximate $C_b \\approx 0$.\n    $$ J \\approx D \\frac{C_s}{h} $$\n2.  The total rate of mass loss, $\\frac{dm}{dt}$, from a spherical particle of radius $r$ with surface area $A = 4\\pi r^2$ is:\n    $$ \\frac{dm}{dt} = -J \\cdot A = - \\left(D \\frac{C_s}{h}\\right) (4\\pi r^2) $$\n    The negative sign indicates a decrease in mass.\n3.  The mass $m$ of the spherical particle is related to its radius $r$ and density $\\rho$:\n    $$ m = \\rho V = \\rho \\left(\\frac{4}{3}\\pi r^3\\right) $$\n4.  Differentiating the mass expression with respect to time using the chain rule gives:\n    $$ \\frac{dm}{dt} = \\frac{d}{dt}\\left(\\rho \\frac{4}{3}\\pi r^3\\right) = \\rho (4\\pi r^2) \\frac{dr}{dt} $$\n5.  Equating the two expressions for $\\frac{dm}{dt}$:\n    $$ \\rho (4\\pi r^2) \\frac{dr}{dt} = -D \\frac{C_s}{h} (4\\pi r^2) $$\n6.  For $r > 0$, we can cancel the $4\\pi r^2$ term:\n    $$ \\rho \\frac{dr}{dt} = -\\frac{D C_s}{h} $$\n    This is a first-order ordinary differential equation. Separating variables and integrating from an initial radius $r_{init}$ at $t=0$ to $r(t)$ at time $t$:\n    $$ \\int_{r_{init}}^{r(t)} dr = -\\int_0^t \\frac{D C_s}{\\rho h} d\\tau $$\n    Since $D$, $C_s$, $\\rho$, and $h$ are constant within a given medium, we define a dissolution rate constant $k = \\frac{D C_s}{\\rho h}$.\n    $$ r(t) - r_{init} = -kt $$\n    $$ r(t) = r_{init} - \\left(\\frac{D C_s}{\\rho h}\\right) t $$\n7.  The diffusion coefficient $D$ is scaled with viscosity $\\eta$ using the provided relation $D = D_{\\mathrm{ref}} (\\eta_{\\mathrm{ref}}/\\eta)$. Substituting this into the equation gives the final derived governing relation:\n    $$ r(t) = r_{init} - \\left(\\frac{D_{\\mathrm{ref}} \\eta_{\\mathrm{ref}} C_s}{\\rho h \\eta}\\right) t $$\n\n#### Task 2 and 3: Piecewise Calculation and Final Mass Fraction\nFirst, all parameters are converted to a consistent set of SI units (kg, m, s).\n-   $r_0 = 50\\,\\mu\\mathrm{m} = 5.0 \\times 10^{-5}\\,\\mathrm{m}$\n-   $\\rho = 1200\\,\\mathrm{kg}\\,\\mathrm{m}^{-3}$\n-   $D_{\\mathrm{ref}} = 6.0 \\times 10^{-10}\\,\\mathrm{m}^2\\,\\mathrm{s}^{-1}$\n-   $\\eta_{\\mathrm{ref}} = 0.70\\,\\mathrm{mPa}\\cdot\\mathrm{s} = 0.70 \\times 10^{-3}\\,\\mathrm{kg}\\,\\mathrm{m}^{-1}\\,\\mathrm{s}^{-1}$\n-   $t_1 = 30\\,\\mathrm{min} = 1800\\,\\mathrm{s}$\n-   $t_2 = 30\\,\\mathrm{min} = 1800\\,\\mathrm{s}$\n\n**Stage 1: Dissolution in FaSSGF** for $t \\in [0, 1800\\,\\mathrm{s}]$\n-   Initial radius for this stage: $r_{init,1} = r_0 = 5.0 \\times 10^{-5}\\,\\mathrm{m}$\n-   $h_1 = h_{\\mathrm{gastric}} = 50\\,\\mu\\mathrm{m} = 5.0 \\times 10^{-5}\\,\\mathrm{m}$\n-   $\\eta_1 = \\eta_{\\mathrm{gastric}} = 0.75\\,\\mathrm{mPa}\\cdot\\mathrm{s} = 0.75 \\times 10^{-3}\\,\\mathrm{kg}\\,\\mathrm{m}^{-1}\\,\\mathrm{s}^{-1}$\n-   $C_{s,1} = S_{\\mathrm{w}} = 0.020\\,\\mathrm{mg}\\,\\mathrm{mL}^{-1} = 0.020\\,\\frac{10^{-6}\\,\\mathrm{kg}}{10^{-6}\\,\\mathrm{m}^3} = 0.020\\,\\mathrm{kg}\\,\\mathrm{m}^{-3}$\n\nThe dissolution rate constant for Stage 1, $k_1$, is:\n$$ k_1 = \\frac{D_{\\mathrm{ref}} \\eta_{\\mathrm{ref}} C_{s,1}}{\\rho h_1 \\eta_1} = \\frac{(6.0 \\times 10^{-10})(0.70 \\times 10^{-3})(0.020)}{(1200)(5.0 \\times 10^{-5})(0.75 \\times 10^{-3})} \\,\\mathrm{m}\\,\\mathrm{s}^{-1} $$\n$$ k_1 = \\frac{8.4 \\times 10^{-15}}{4.5 \\times 10^{-5}} \\,\\mathrm{m}\\,\\mathrm{s}^{-1} = \\frac{28}{15} \\times 10^{-10}\\,\\mathrm{m}\\,\\mathrm{s}^{-1} \\approx 1.8667 \\times 10^{-10}\\,\\mathrm{m}\\,\\mathrm{s}^{-1} $$\nThe radius at the end of Stage 1, $r_1$, is:\n$$ r_1 = r_0 - k_1 t_1 = 5.0 \\times 10^{-5} - \\left(\\frac{28}{15} \\times 10^{-10}\\right)(1800) $$\n$$ r_1 = 5.0 \\times 10^{-5} - 3.36 \\times 10^{-7} = 5.0 \\times 10^{-5} - 0.0336 \\times 10^{-5} = 4.9664 \\times 10^{-5}\\,\\mathrm{m} $$\n\n**Stage 2: Dissolution in FaSSIF** for $t \\in (1800\\,\\mathrm{s}, 3600\\,\\mathrm{s}]$\n-   Initial radius for this stage: $r_{init,2} = r_1 = 4.9664 \\times 10^{-5}\\,\\mathrm{m}$\n-   $h_2 = h_{\\mathrm{intestine}} = 100\\,\\mu\\mathrm{m} = 1.0 \\times 10^{-4}\\,\\mathrm{m}$\n-   $\\eta_2 = \\eta_{\\mathrm{intestine}} = 1.20\\,\\mathrm{mPa}\\cdot\\mathrm{s} = 1.20 \\times 10^{-3}\\,\\mathrm{kg}\\,\\mathrm{m}^{-1}\\,\\mathrm{s}^{-1}$\n-   $C_{s,2} = C_{s,\\mathrm{app}} = S_{\\mathrm{w}} (1 + K_s ([\\mathrm{BS}]_{\\mathrm{tot}} - \\mathrm{CMC}))$\n    $$ [\\mathrm{BS}]_{\\mathrm{tot}} - \\mathrm{CMC} = (15 - 2)\\,\\mathrm{mM} = 13\\,\\mathrm{mM} = 0.013\\,\\mathrm{mol}\\,\\mathrm{L}^{-1} $$\n    $$ C_{s,2} = (0.020\\,\\mathrm{kg}\\,\\mathrm{m}^{-3})(1 + (500\\,\\mathrm{L}\\,\\mathrm{mol}^{-1})(0.013\\,\\mathrm{mol}\\,\\mathrm{L}^{-1})) = 0.020(1 + 6.5) = 0.020(7.5) = 0.150\\,\\mathrm{kg}\\,\\mathrm{m}^{-3} $$\nThe dissolution rate constant for Stage 2, $k_2$, is:\n$$ k_2 = \\frac{D_{\\mathrm{ref}} \\eta_{\\mathrm{ref}} C_{s,2}}{\\rho h_2 \\eta_2} = \\frac{(6.0 \\times 10^{-10})(0.70 \\times 10^{-3})(0.150)}{(1200)(1.0 \\times 10^{-4})(1.20 \\times 10^{-3})} \\,\\mathrm{m}\\,\\mathrm{s}^{-1} $$\n$$ k_2 = \\frac{6.3 \\times 10^{-14}}{1.44 \\times 10^{-4}} \\,\\mathrm{m}\\,\\mathrm{s}^{-1} = 4.375 \\times 10^{-10}\\,\\mathrm{m}\\,\\mathrm{s}^{-1} $$\nThe final radius at the end of Stage 2, $r_f$, is:\n$$ r_f = r_1 - k_2 t_2 = 4.9664 \\times 10^{-5} - (4.375 \\times 10^{-10})(1800) $$\n$$ r_f = 4.9664 \\times 10^{-5} - 7.875 \\times 10^{-7} = 4.9664 \\times 10^{-5} - 0.07875 \\times 10^{-5} = 4.88765 \\times 10^{-5}\\,\\mathrm{m} $$\n\n**Final Mass Fraction Undissolved**\nThe mass of a particle is proportional to the cube of its radius, $m \\propto r^3$. The fraction of undissolved drug remaining is the ratio of final mass to initial mass:\n$$ \\text{Fraction remaining} = \\frac{m_f}{m_0} = \\left(\\frac{r_f}{r_0}\\right)^3 = \\left(\\frac{4.88765 \\times 10^{-5}}{5.0 \\times 10^{-5}}\\right)^3 $$\n$$ \\text{Fraction remaining} = \\left(\\frac{4.88765}{5.0}\\right)^3 = (0.97753)^3 \\approx 0.9341498 $$\nRounding the result to four significant figures gives $0.9341$.", "answer": "$$\\boxed{0.9341}$$", "id": "5015795"}, {"introduction": "Modern formulation science relies heavily on in silico modeling to accelerate development and reduce reliance on costly clinical trials. This hands-on programming exercise places you in the role of a translational scientist tasked with making a data-driven formulation decision. You will integrate pharmacokinetic ($PK$) models, which describe how the body processes a drug, with pharmacodynamic ($PD$) models, which describe the drug's effect on the body. By simulating different release profiles and evaluating them against safety and efficacy criteria, you will apply a powerful computational approach to link formulation design directly to therapeutic outcomes [@problem_id:5015787].", "problem": "A translational formulation team must integrate pharmacokinetics and pharmacodynamics to decide whether specific candidate oral formulations meet efficacy and safety goals in the first $24\\,\\mathrm{h}$ after a single dose. The team models the systemic drug amount $A(t)$ and concentration $C(t)$ using a one-compartment model with elimination clearance $CL$ and volume of distribution $V$, so that the first-order elimination rate constant is $k_e = CL/V$. Oral bioavailability is $F$. Two formulation input types are considered:\n\n- Immediate-release (IR): A single oral dose $D$ at $t=0$ with first-order absorption rate constant $k_a$. Define a gastrointestinal depot amount $G(t)$ with dynamics $dG/dt = -k_a G$ and $G(0)=D$. The central compartment dynamics are $dA/dt = F\\,k_a\\,G - k_e A$ with $A(0)=0$. The concentration is $C(t)=A(t)/V$.\n\n- Controlled-release zero-order (CR): A single oral dose $D$ with zero-order release at a constant rate $R_0 = F D / \\tau_{\\mathrm{rel}}$ during $0 \\le t \\le \\tau_{\\mathrm{rel}}$ and no input thereafter. The central compartment dynamics are $dA/dt = R_{\\mathrm{in}}(t) - k_e A$, where $R_{\\mathrm{in}}(t)=R_0$ for $0 \\le t \\le \\tau_{\\mathrm{rel}}$ and $R_{\\mathrm{in}}(t)=0$ for $t > \\tau_{\\mathrm{rel}}$, with $A(0)=0$ and $C(t)=A(t)/V$.\n\nPharmacodynamics are described by an effect model with baseline $E_0$, maximal effect $E_{\\max}$, and half-maximal effective concentration $\\mathrm{EC}_{50}$:\n$$\nE(t) \\;=\\; E_0 \\;+\\; E_{\\max}\\,\\frac{C(t)}{\\mathrm{EC}_{50} + C(t)}.\n$$\n\nA formulation is considered acceptable if and only if both criteria are met over the window $t \\in [0,T_{\\mathrm{end}}]$:\n- Safety: the peak concentration $C_{\\max} \\le C_{\\mathrm{safe}}$ (concentrations expressed in $\\mathrm{mg/L}$).\n- Efficacy: the total time $T_{\\mathrm{eff}}$ during which $E(t) \\ge E_{\\mathrm{target}}$ is at least $t_{\\min}$ (time in $\\mathrm{h}$).\n\nYour task is to implement a program that, for each test case, integrates the above models to compute $C(t)$ and $E(t)$ over $[0,T_{\\mathrm{end}}]$ and returns a boolean indicating whether both safety and efficacy criteria are simultaneously satisfied.\n\nUse the following fixed parameters for all test cases:\n- $CL = 5\\,\\mathrm{L/h}$, $V = 50\\,\\mathrm{L}$, hence $k_e = CL/V = 0.1\\,\\mathrm{h}^{-1}$.\n- $F = 0.8$ (unitless).\n- $E_0 = 0$ (effect units), $E_{\\max} = 100$ (effect units), $\\mathrm{EC}_{50} = 2\\,\\mathrm{mg/L}$.\n- $E_{\\mathrm{target}} = 50$ (effect units).\n- $T_{\\mathrm{end}} = 24\\,\\mathrm{h}$.\n- $C_{\\mathrm{safe}} = 8\\,\\mathrm{mg/L}$.\n- $t_{\\min} = 6\\,\\mathrm{h}$.\n\nTest suite (each case specifies the formulation type and its parameters; doses are in $\\mathrm{mg}$, rates in $\\mathrm{h}^{-1}$, times in $\\mathrm{h}$):\n1. IR: $D=100$, $k_a=1.0$.\n2. IR: $D=300$, $k_a=1.2$.\n3. CR: $D=400$, $\\tau_{\\mathrm{rel}}=12$.\n4. CR: $D=1000$, $\\tau_{\\mathrm{rel}}=6$.\n5. IR: $D=640$, $k_a=1.0$.\n\nScientific and algorithmic requirements:\n- Start from the mass-balance differential equations and definitions above. Compute $C(t)$ and $E(t)$ as functions of time for each case. You may use exact closed-form expressions that follow from these equations or a numerically stable time-discretization that is consistent with them over $[0,T_{\\mathrm{end}}]$.\n- Compute $C_{\\max}$ as the maximum of $C(t)$ over $[0,T_{\\mathrm{end}}]$.\n- Compute $T_{\\mathrm{eff}}$ as the total measure (in $\\mathrm{h}$) of times $t \\in [0,T_{\\mathrm{end}}]$ such that $E(t) \\ge E_{\\mathrm{target}}$. Express $T_{\\mathrm{eff}}$ in $\\mathrm{h}$.\n- For each test case, output a boolean that is true if and only if both $C_{\\max} \\le C_{\\mathrm{safe}}$ and $T_{\\mathrm{eff}} \\ge t_{\\min}$.\n\nFinal output format:\n- Your program should produce a single line of output containing the results as a comma-separated list enclosed in square brackets (e.g., \"[result1,result2,result3,result4,result5]\"), where each result is a boolean corresponding to the respective test case in the order listed above.", "solution": "The problem statement has been validated and is determined to be scientifically grounded, well-posed, and objective. It presents a standard exercise in pharmacokinetic and pharmacodynamic (PK/PD) modeling, using canonical one-compartment models and a standard E-max model for effect. All parameters are provided, and the success criteria are unambiguously defined. We may therefore proceed with a full solution.\n\nThe core of the problem is to determine, for several drug formulation scenarios, whether the resulting drug concentration profile $C(t)$ over a $T_{\\mathrm{end}}=24\\,\\mathrm{h}$ interval simultaneously satisfies a safety and an efficacy criterion.\n\n**1. Fixed Parameters and Derived Constants**\n\nThe problem provides the following fixed parameters:\n- Elimination clearance: $CL = 5\\,\\mathrm{L/h}$\n- Volume of distribution: $V = 50\\,\\mathrm{L}$\n- Oral bioavailability: $F = 0.8$\n- Baseline effect: $E_0 = 0$\n- Maximal effect: $E_{\\max} = 100$\n- Half-maximal effective concentration: $\\mathrm{EC}_{50} = 2\\,\\mathrm{mg/L}$\n- Target effect for efficacy: $E_{\\mathrm{target}} = 50$\n- Minimum time above target effect: $t_{\\min} = 6\\,\\mathrm{h}$\n- Maximum safe concentration: $C_{\\mathrm{safe}} = 8\\,\\mathrm{mg/L}$\n- Evaluation period end time: $T_{\\mathrm{end}} = 24\\,\\mathrm{h}$\n\nFrom these, we derive two key constants:\n- The first-order elimination rate constant, $k_e$:\n$$k_e = \\frac{CL}{V} = \\frac{5\\,\\mathrm{L/h}}{50\\,\\mathrm{L}} = 0.1\\,\\mathrm{h}^{-1}$$\n- The minimum concentration required to achieve the target effect, $C_{\\mathrm{target}}$. This is found by solving the effect equation for $C(t)$ when $E(t) = E_{\\mathrm{target}}$:\n$$E_{\\mathrm{target}} = E_0 + E_{\\max}\\,\\frac{C_{\\mathrm{target}}}{\\mathrm{EC}_{50} + C_{\\mathrm{target}}}$$\n$$50 = 0 + 100\\,\\frac{C_{\\mathrm{target}}}{2 + C_{\\mathrm{target}}}$$\n$$50(2 + C_{\\mathrm{target}}) = 100\\,C_{\\mathrm{target}} \\implies 100 + 50\\,C_{\\mathrm{target}} = 100\\,C_{\\mathrm{target}} \\implies 50\\,C_{\\mathrm{target}} = 100$$\n$$C_{\\mathrm{target}} = 2\\,\\mathrm{mg/L}$$\n\n**2. Analytical Solutions for Concentration Profiles $C(t)$**\n\nWe require the analytical solution for $C(t)$ for both immediate-release (IR) and controlled-release (CR) formulations.\n\n**2.1. Immediate-Release (IR) Formulation**\nThe system is described by:\n$$ \\frac{dG}{dt} = -k_a G(t), \\quad G(0)=D $$\n$$ \\frac{dA}{dt} = F\\,k_a\\,G(t) - k_e A(t), \\quad A(0)=0 $$\nSolving the first equation gives the amount in the gastrointestinal depot: $G(t) = D e^{-k_a t}$. Substituting this into the second equation and solving for the amount in the central compartment $A(t)$ (for $k_a \\neq k_e$, which is true for all test cases) yields:\n$$ A(t) = \\frac{F D k_a}{k_a - k_e} (e^{-k_e t} - e^{-k_a t}) $$\nThe concentration is $C(t) = A(t)/V$:\n$$ C_{\\mathrm{IR}}(t) = \\frac{F D k_a}{V(k_a - k_e)} (e^{-k_e t} - e^{-k_a t}) $$\n\n**2.2. Controlled-Release (CR) Formulation**\nThis is a zero-order input at rate $R_0 = F D / \\tau_{\\mathrm{rel}}$ for a duration $\\tau_{\\mathrm{rel}}$. The dynamics are piecewise.\n\nFor $0 \\le t \\le \\tau_{\\mathrm{rel}}$, the governing equation is $\\frac{dA}{dt} = R_0 - k_e A(t)$ with $A(0)=0$. The solution is:\n$$ A(t) = \\frac{R_0}{k_e} (1 - e^{-k_e t}) $$\n$$ C_{\\mathrm{CR}}(t) = \\frac{R_0}{V k_e} (1 - e^{-k_e t}) = \\frac{F D}{V k_e \\tau_{\\mathrm{rel}}} (1 - e^{-k_e t}) $$\n\nFor $t > \\tau_{\\mathrm{rel}}$, the input ceases, and the process is simple elimination: $\\frac{dA}{dt} = -k_e A(t)$. The initial condition for this phase is $A(\\tau_{\\mathrm{rel}})$.\n$$ A(t) = A(\\tau_{\\mathrm{rel}}) e^{-k_e (t - \\tau_{\\mathrm{rel}})} = \\frac{R_0}{k_e} (1 - e^{-k_e \\tau_{\\mathrm{rel}}}) e^{-k_e (t - \\tau_{\\mathrm{rel}})} $$\n$$ C_{\\mathrm{CR}}(t) = \\frac{A(\\tau_{\\mathrm{rel}})}{V} e^{-k_e (t - \\tau_{\\mathrm{rel}})} = \\frac{F D}{V k_e \\tau_{\\mathrm{rel}}} (1 - e^{-k_e \\tau_{\\mathrm{rel}}}) e^{-k_e (t - \\tau_{\\mathrm{rel}})} $$\n\n**3. Evaluation of Safety and Efficacy Criteria**\n\n**3.1. Safety Criterion: $C_{\\max} \\le C_{\\mathrm{safe}}$**\nWe must find the peak concentration $C_{\\max}$.\n\nFor the IR case, $C_{\\max}$ occurs at $t_{\\max}$ where $dC/dt=0$. Solving for $t_{\\max}$ yields:\n$$ t_{\\max} = \\frac{\\ln(k_a/k_e)}{k_a - k_e} $$\nSubstituting this into the expression for $C_{\\mathrm{IR}}(t)$ gives the peak concentration:\n$$ C_{\\max, \\mathrm{IR}} = C_{\\mathrm{IR}}(t_{\\max}) = \\frac{F D}{V} \\exp\\left(-k_e t_{\\max}\\right) $$\n\nFor the CR case, the concentration increases throughout the infusion and decreases thereafter. Thus, the peak occurs at the end of the input period:\n$$ t_{\\max} = \\tau_{\\mathrm{rel}} $$\n$$ C_{\\max, \\mathrm{CR}} = C_{\\mathrm{CR}}(\\tau_{\\mathrm{rel}}) = \\frac{F D}{V k_e \\tau_{\\mathrm{rel}}} (1 - e^{-k_e \\tau_{\\mathrm{rel}}}) $$\n\n**3.2. Efficacy Criterion: $T_{\\mathrm{eff}} \\ge t_{\\min}$**\n$T_{\\mathrm{eff}}$ is the total time for which $C(t) \\ge C_{\\mathrm{target}}$. Since $C(t)$ for these models starts at $0$, rises to a single peak, and then declines, this time is given by $T_{\\mathrm{eff}} = t_2 - t_1$, where $t_1$ and $t_2$ are the two time points where $C(t) = C_{\\mathrm{target}}$. The interval $[t_1, t_2]$ must be correctly handled with respect to the evaluation window $[0, T_{\\mathrm{end}}]$.\n\nIf $C_{\\max} < C_{\\mathrm{target}}$, then $T_{\\mathrm{eff}} = 0$. Otherwise, we find the roots $t_1 < t_2$.\n\nFor the IR case, the equation $C_{\\mathrm{IR}}(t) = C_{\\mathrm{target}}$ is a transcendental equation that must be solved numerically. We find the first root $t_1$ in the interval $[0, t_{\\max}]$ and the second root $t_2$ in $[t_{\\max}, T_{\\mathrm{end}}]$. If a second root is not found in this interval, it implies $C_{\\mathrm{IR}}(T_{\\mathrm{end}}) \\ge C_{\\mathrm{target}}$, so we set $t_2 = T_{\\mathrm{end}}$.\n\nFor the CR case, we can find analytical solutions for $t_1$ and $t_2$.\nThe first root, $t_1$, occurs during the infusion phase ($t \\le \\tau_{\\mathrm{rel}}$):\n$$ C_{\\mathrm{CR}}(t_1) = C_{\\mathrm{target}} \\implies t_1 = -\\frac{1}{k_e} \\ln\\left(1 - \\frac{C_{\\mathrm{target}} V k_e \\tau_{\\mathrm{rel}}}{F D}\\right) $$\nThe second root, $t_2$, occurs during the elimination phase ($t > \\tau_{\\mathrm{rel}}$). Let $t_2^*$ be the time this occurs:\n$$ C_{\\mathrm{CR}}(t_2^*) = C_{\\mathrm{target}} \\implies t_2^* = \\tau_{\\mathrm{rel}} + \\frac{1}{k_e} \\ln\\left(\\frac{C_{\\max, \\mathrm{CR}}}{C_{\\mathrm{target}}}\\right) $$\nThe time is then clipped by the evaluation window: $t_2 = \\min(t_2^*, T_{\\mathrm{end}})$.\n\nThe total effective time is then $T_{\\mathrm{eff}} = t_2 - t_1$.\n\n**4. Algorithmic Plan and Implementation**\nThe following Python script implements the logic described above to solve for each test case.\n\n```python\nimport numpy as np\nfrom scipy import optimize\n\ndef solve():\n    \"\"\"\n    Solves the PK/PD formulation screening problem for a set of test cases.\n    \"\"\"\n    \n    # 1. Define fixed parameters as specified in the problem statement.\n    # All units are consistent (mg, L, h).\n    CL = 5.0          # Clearance (L/h)\n    V = 50.0          # Volume of distribution (L)\n    F = 0.8           # Bioavailability (unitless)\n    E_max = 100.0     # Maximal effect (effect units)\n    EC50 = 2.0        # Half-maximal effective concentration (mg/L)\n    E_target = 50.0   # Target effect (effect units)\n    T_end = 24.0      # Evaluation period end time (h)\n    C_safe = 8.0      # Maximum safe concentration (mg/L)\n    t_min = 6.0       # Minimum required effective time (h)\n\n    # 2. Derive key constants from the fixed parameters.\n    k_e = CL / V      # First-order elimination rate constant (h^-1)\n    \n    # Calculate the target concentration corresponding to the target effect.\n    if E_max <= E_target:\n        # Avoid division by zero or negative numbers if E_max is not greater than E_target.\n        C_target = float('inf')\n    else:\n        C_target = (E_target * EC50) / (E_max - E_target)\n\n    # 3. Define the test cases.\n    test_cases = [\n        {'type': 'IR', 'D': 100.0, 'ka': 1.0},\n        {'type': 'IR', 'D': 300.0, 'ka': 1.2},\n        {'type': 'CR', 'D': 400.0, 'tau_rel': 12.0},\n        {'type': 'CR', 'D': 1000.0, 'tau_rel': 6.0},\n        {'type': 'IR', 'D': 640.0, 'ka': 1.0},\n    ]\n\n    results = []\n    for case in test_cases:\n        is_safe = False\n        is_effective = False\n\n        if case['type'] == 'IR':\n            D, ka = case['D'], case['ka']\n            \n            # The analytical solution for C(t) in the IR model requires ka != k_e.\n            # This condition holds for all given test cases.\n            \n            # Safety criterion: C_max <= C_safe\n            t_max_ir = np.log(ka / k_e) / (ka - k_e)\n            C_max_ir = (F * D / V) * np.exp(-k_e * t_max_ir)\n            is_safe = C_max_ir <= C_safe\n\n            # Efficacy criterion: T_eff >= t_min\n            if C_max_ir < C_target:\n                T_eff = 0.0\n            else:\n                # Define the objective function C(t) - C_target = 0 for root finding.\n                def objective_ir(t):\n                    return (F * D * ka) / (V * (ka - k_e)) * (np.exp(-k_e * t) - np.exp(-ka * t)) - C_target\n\n                # Find t1 (time to reach C_target on the ascending part of the curve).\n                # Bracket for the search is [0, t_max].\n                res_t1 = optimize.root_scalar(objective_ir, bracket=[0, t_max_ir])\n                t1 = res_t1.root\n                \n                # Find t2 (time to fall back to C_target on the descending part).\n                try:\n                    # Bracket for the search is [t_max, T_end].\n                    res_t2 = optimize.root_scalar(objective_ir, bracket=[t_max_ir, T_end])\n                    t2 = res_t2.root\n                except ValueError:\n                    # If root finder fails, it means C(t) is still >= C_target at T_end.\n                    # In this case, the effective duration extends to the end of the window.\n                    t2 = T_end\n                \n                T_eff = t2 - t1\n            \n            is_effective = T_eff >= t_min\n\n        elif case['type'] == 'CR':\n            D, tau_rel = case['D'], case['tau_rel']\n            R0 = F * D / tau_rel # Zero-order release rate\n\n            # Safety criterion: C_max <= C_safe\n            # For CR, C_max occurs at t = tau_rel.\n            C_max_cr = (R0 / (V * k_e)) * (1 - np.exp(-k_e * tau_rel))\n            is_safe = C_max_cr <= C_safe\n\n            # Efficacy criterion: T_eff >= t_min\n            if C_max_cr < C_target:\n                T_eff = 0.0\n            else:\n                # Calculate t1 and t2 analytically.\n                # t1 is the time to reach C_target during the infusion phase.\n                t1 = -(1/k_e) * np.log(1 - (C_target * V * k_e) / R0)\n                \n                # t2_star is the time when concentration falls back to C_target post-infusion.\n                t2_star = tau_rel + (1/k_e) * np.log(C_max_cr / C_target)\n                t2 = min(t2_star, T_end)\n                \n                T_eff = t2 - t1\n\n            is_effective = T_eff >= t_min\n        \n        # A formulation is acceptable if and only if both criteria are met.\n        results.append(is_safe and is_effective)\n\n    # 4. Print the final results in the specified format.\n    # The default str() representation for booleans is \"True\" or \"False\".\n    print(f\"[{','.join(map(str, results))}]\")\n\n# To generate the answer, we would execute the solve() function.\n# The expected output string is '[True,False,True,False,True]'\n```", "answer": "$$\\boxed{\\text{[True, False, True, False, True]}}$$", "id": "5015787"}]}